08.3 – How did lung cancer groups rally to inform patients during COVID-19?

 
 
00:00 /
 
1X
 

Living with lung cancer comes with many challenges, especially during the COVID-19 era. Unfortunately, information about how COVID-19 affects lung cancer patients is hard to come by. Stepping into this void, lung cancer advocacy groups have worked together to produce consistent resources with the latest learnings, updates, and information to help those living with lung cancer during COVID-19.

Guests

Janet Freeman-Daily is a lung cancer patient and activist who brings her engineering background to research advocacy.

Upal Basu Roy, PhD, MPH, LUNGevity Vice President of Research. Dr. Roy is responsible for setting strategy and overseeing LUNGevity’s scientific research awards programs and has a background in public health.

Amy Moore, PhD, Go2 Foundation for Lung Cancer. Dr. Moore, virologist and cancer researcher, is a highly sought-after expert regarding the intersection of lung cancer and COVID-19.

Resource:

Coronavirus and Lung Cancer: Joint Statement From Lung Cancer Advocacy Groups

Episode 8.3 Show Notes

Subscribe on Google Play
Subscribe on iTunes
Get the podcast at Stitcher

You might find this interesting